您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (10): 41-45.doi: 10.6040/j.issn.1671-7554.0.2016.1522

• 基础医学 • 上一篇    下一篇

CD11b+/CD66b-表型髓系细胞在结肠癌进展和肝转移中的作用

王贲士1, 单军奇1,2,侯庆生1,公为鹏1,朱振宇1,郭洪亮1   

  1. 1.山东省肿瘤医院外科四病区, 山东 济南 250117;2.济南大学 山东医学科学院与生命科学学院, 山东 济南 250022
  • 收稿日期:2016-11-17 出版日期:2017-10-10 发布日期:2017-10-10
  • 通讯作者: 郭洪亮. E-mail: hliangbb@163.com E-mail:hliangbb@163.com
  • 基金资助:
    山东省自然科学基金(ZR2013HL045)

Effort of CD11b+ / CD66b- phenotype myeloid cells on the progression of colon cancer and liver metastasis

WANG Bishi1, SHAN Junqi1,2, HOU Qingsheng1, GONG Weipeng1, ZHU Zhenyu1, GUO Hongliang1   

  1. 1. The fourth department of surgical ward, Shandong Cancer Hospital, Jinan 250117, Shandong, China;
    2.School of Medicine and Life Science, University of Jinan-Shandong Academy of Medical Sciences, Jinan 250022, Shandong, China
  • Received:2016-11-17 Online:2017-10-10 Published:2017-10-10

PDF (PC)

1075

摘要： 目的 探讨CD11b+/CD66b-表型髓系细胞与人类结肠癌进展和肝转移的关系。 方法 采用real-time PCR、Western blotting及免疫组化方法检测正常结肠组织、结肠癌组织及结肠癌肝转移组织中CD11b、趋化因子配体2(CCL2)和趋化因子受体2(CCR2)的转录水平、蛋白翻译水平。免疫共沉淀方法检测CCL2和CCR2间的相互结合关系。 结果 结肠癌组织、肝转移瘤组织的CD11b mRNA转录水平及蛋白的表达水平较癌旁正常组织高(P<0.05)。肝转移瘤组织中CCL2 的mRNA转录水平及蛋白的表达水平明显高于癌旁正常结肠组织及结肠癌组织(P<0.05),而CCR2mRNA转录水平及蛋白表达水平在三者中无统计学差异(P>0.05)。趋化因子配体CCL2和趋化因子受体CCR2之间可相互结合。 结论 CD11b表型髓系细胞在结肠癌组织及结肠癌肝转移组织中广泛浸润,并可能在CCL2-CCR2轴的介导下促进结肠癌进展和结肠癌肝转移。

关键词: 结肠癌, 肝转移, CD11b+/CD66b-表型髓系细胞, 趋化因子受体2, 趋化因子配体2

Abstract: Objective To study the relationship between CD11b+/ CD66b- phenotype myeloid cells and colon cancer progression and liver metastasis. Methods The transcription level, protein translation levels of CD11b, chemokine C-C motif ligand 2(CCL2)and chemokine C-C motif receptor type 2(CCR2)in colonic carcinoma tissues, colorectal cancer tissues and liver metastasis were detected by real-time PCR, Western blotting and immunohistochemistry. The co-immunoprecipitation method was used to detect the relationship between CCL2 and CCR2. Results The expression of CD11b mRNA in colorectal carcinoma and liver metastasis was higher than that in normal tissues(P<0.05). The level of CCL2 mRNA transcription and protein expression in liver metastasis was significantly higher than that in normal colonic tissues and colon cancer tissues(P<0.05). The level of CCR2 mRNA transcription and protein expression in the three were no significant difference(P>0.05). Chemokine ligand CCL2 and chemokine receptor CCR2 can be combined with each other. Conclusion CD11b phenotype myeloid cell is extensive infiltration in colon cancer and liver metastasis of colon cancer tissue, and possibly can promote the progression of colon cancer and liver metastasis of colonic carcinoma by mediating with CCL2-CCR2 axis.

Key words: Liver metastasis, Chemokine C-C motif receptor type 2, Colorectal cancer, CD11b+/CD66b-Myeloid cells, Chemokine C-C motif ligand 2

中图分类号: 

  • R735.3+5
[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132 PMID:26808342
[2] 李德錄, 吴春晓, 郑莹, 等. 上海市2003~2007年结直肠癌发病率和死亡率分析[J]. 中国肿瘤,2011, 20(6):413-418. LI Delu, WU Chunxiao, ZHENG Ying, et al. Incidence and mortality of colorectal cancer in Shanghai from 2003 to 2007[J] China Cancer, 2011, 20(6):413-418.
[3] Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer[J]. Ann Surg, 2006, 244(2):254-259.
[4] Zhao L, Lim SY, Gordon-Weeks AN, et al. Recruitment of a myeloid cell subset(CD11b/Gr1 mid)via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis[J]. Hepatology, 2013, 57(2):829-839.
[5] Venneri MA, De Palma M, Ponzoni M, et al. Identification of proangiogenic TIE2-expressing monocytes(TEMs)in human peripheral blood and cancer[J]. Blood, 2007, 109(12):5276-5285.
[6] 中华人民共和国卫生和计划生育委员会医政医管局. 中国结直肠癌诊疗规范(2015版)[J]. 中华消化外科杂志, 2015, 14(10):783-799.
[7] Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer[J]. N Engl J Med, 2005, 353(25):2654-2666.
[8] Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis[J]. Cancer Cell, 2004, 6(4):409-421.
[9] Cross SS, Hamdy FC, Deloulme JC, et al. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers[J]. Histopathology, 2005, 46(3):256-269.
[10] Connolly MK, Mallen-St Clair J, Bedrosian AS, et al. Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor[J]. J Leukoc Biol, 2010, 87(4):713-725.
[11] Forssell J, Oberg A, Henriksson ML, et al. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer[J]. Clin Cancer Res, 2007, 13(5):1472-1479.
[12] Hakansson L, Adell G, Boeryd B, et al. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis[J]. Br J Cancer, 1997, 75(3):374-380.
[13] Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment[J]. J Clin Invest, 2004, 113(7):1040-1050.
[14] Serbina NV, Salazar-Mather TP, Biron CA, et al. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection[J]. Immunity,2003, 19(1):59-70.
[15] Bosschaerts T, Guilliams M, Stijlemans B, et al. Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling[J]. PLoS Pathog, 2010,6(8): e1001045.
[16] Aldridge JR, Jr., Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection[J]. Proc Natl Acad Sci U S A, 2009, 106(13):5306-5311.
[17] Yin L S, Yuzhalin A E, Gordon-Weeks A N, et al. Targeting the CCL2-CCR2 signaling axis in cancer metastasis[J]. Oncotarget, 2016, 7(19):28697-28710.
[1] 刘爱静,李雁儒,高惠茹,段伟丽,李培龙,李娟,杜鲁涛,王传新. 自噬相关蛋白5在结肠癌中的表达及对结肠癌细胞迁移及侵袭能力的影响[J]. 山东大学学报 (医学版), 2024, 62(4): 14-23.
[2] 梁永媛,蔡培飞,郑桂喜. 基于多检验变量和机器学习算法的结肠癌诊断模型建立及价值评估[J]. 山东大学学报 (医学版), 2024, 62(2): 51-59.
[3] 甄秋来,吕欣然,叶辉,丁绪超,柴小雪,胡辛,周明,曹莉莉. 基于TCGA数据库预测结肠癌预后基因及其临床应用价值[J]. 山东大学学报 (医学版), 2021, 59(1): 64-71.
[4] 洪甲庚,聂洋洋,苏国强. 丙泊酚对结肠癌细胞增殖、迁移及Wnt1和β-catenin表达的影响[J]. 山东大学学报 (医学版), 2020, 58(11): 53-58.
[5] 周嘉晖,王刚,刘江,赵健,王海锋,江志伟. 加速康复外科指导下的多模式镇痛对开腹结肠癌患者术后恢复的影响[J]. 山东大学学报 (医学版), 2019, 57(9): 38-42.
[6] 万秀霞,孙秀萍,佟晶洁. 大黄酚对结肠癌的抗肿瘤作用[J]. 山东大学学报 (医学版), 2019, 57(5): 74-79.
[7] 高振文,杨淑萍,谢雪雪,宋伟. Yes相关蛋白与结肠癌病理因素的相关性[J]. 山东大学学报 (医学版), 2018, 56(7): 57-64.
[8] 朱宇,王宏洁,韩彬彬,冯莎娜,张春,李学祥,韩晓红,崔巍. 人异常凝血酶原(PIVKA-II)在监测结直肠癌肝转移中的应用[J]. 山东大学学报 (医学版), 2018, 56(10): 58-63.
[9] 刘惠苓,王兴文,冯少滨,冯虹,韩俊庆. B类I型清道夫受体的高表达与结肠癌患者预后的相关性[J]. 山东大学学报（医学版）, 2017, 55(10): 84-89.
[10] 张雪群,高卫,潘盼,高骏逸. PI3K/AKT及其相关因子在结肠癌中的表达[J]. 山东大学学报（医学版）, 2016, 54(1): 52-57.
[11] 王尧, 陈艳红, 陈宏. 结肠癌患者外周血DPYD基因多态性与5-FU敏感性和毒副作用相关性分析[J]. 山东大学学报（医学版）, 2014, 52(S1): 18-21.
[12] 孟宪鹏1，刘杰2，苏娅3，邴雪4，高卫2. SU11274对人结肠癌LOVO细胞裸鼠移植瘤的抑制作用[J]. 山东大学学报（医学版）, 2014, 52(2): 20-24.
[13] 李雪梅1, 颜世平1, 宿敬然2，程兆令1, 朱强1. TIPE2在结肠癌发展中的作用及分子机制[J]. 山东大学学报（医学版）, 2014, 52(1): 20-22.
[14] 孙秀梅1，高峰2，刘子凤3. 盐霉素对结肠癌干细胞特性的抑制作用[J]. 山东大学学报(医学版), 2013, 51(9): 40-44.
[15] 任鹏1，郝青2，王杰书3，李洪林3，李波3，王峰3. 趋化因子受体3及血管生成拟态在结肠癌肝转移中的作用[J]. 山东大学学报(医学版), 2012, 50(8): 96-99.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发